Atlas Trials

A Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors

Clinical trial NCT06520488 · RECRUITING

Trial details

NCT number
NCT06520488
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Solid Tumors
Start date
2024-08-09
Primary completion
2027-03-01
Enrollment
118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.